Samaneh Pourajam
Overview
Explore the profile of Samaneh Pourajam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
63
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akbari M, Dehghani Y, Shirzadi M, Pourajam S, Hosseinzadeh M, Sajadi M, et al.
Front Public Health
. 2024 Sep;
12:1411314.
PMID: 39314786
Background: Epidemiological data regarding the prevalence of bacterial multidrug-resistant (MDR) Gram-negative infections in patients with COVID-19 in Iran are still ambiguous. Thus, in this study we have investigated the epidemiology,...
2.
Nikbin V, Khiavi E, Dehghani-Latani M, Hosseinzadeh M, Shirzadi M, Pourajam S, et al.
Eur J Clin Microbiol Infect Dis
. 2024 Jul;
43(10):2023-2027.
PMID: 39073671
Carbapenem-resistant organisms (CRO) represent a significant threat because of their widespread in hospital settings, difficult-to-treat, and association with high morbidity and mortality rates. Data on the efficacy of ceftazidime/avibactam (CAZ-AVI)...
3.
Moeinzadeh F, Raeisi V, Babahajiani M, Mortazavi M, Pourajam S, Seirafian S, et al.
Adv Biomed Res
. 2023 Apr;
12:39.
PMID: 37057234
Background: Chronic kidney disease (CKD) is an important comorbidity in Coronavirus Disease 2019 (COVID-19) patients considering its high prevalence. We aimed to figure out the relationship between CKD and COVID-19...
4.
Amra B, Ashrafi F, Torki M, Hashemi M, Shirzadi M, Soltaninejad F, et al.
Adv Biomed Res
. 2023 Mar;
12:14.
PMID: 36926422
Background: Coronavirus disease 2019 has become a public health concern with a high number of fatalities. Thalidomide can target inflammatory mediators and decrease inflammation in SARS-CoV-2. Materials And Methods: An...
5.
Zahedi N, Pourajam S, Zaker E, Kouhpayeh S, Mirbod S, Tavangar M, et al.
Environ Res
. 2023 Mar;
226:115674.
PMID: 36925035
Cardiovascular diseases (CVDs) as environmental-influenced disorders, are a major concern and the leading cause of death worldwide. A range of therapeutic approaches has been proposed, including conventional and novel methods....
6.
Pourajam S, Zafarbakhsh A, Hosseinzadeh M, Shirzadi M, Siavash M, Solgi H
J Pharm Policy Pract
. 2023 Mar;
16(1):38.
PMID: 36869363
During the COVID-19 pandemic, the rapid emergence of carbapenem and colistin-resistant Klebsiella pneumoniae has resulted in an alarming situation worldwide. We aimed to describe secondary infections and antimicrobial use, in...
7.
Sadeghi S, Nasri P, Nasri E, Solgi H, Nasirian M, Pourajam S, et al.
J Res Med Sci
. 2022 Aug;
27:43.
PMID: 35968207
Background: Since December 2019, the world is struggling with an outbreak of coronavirus disease-2019 (COVID-19) infection mostly represented as an acute respiratory distress syndrome and has turned into the most...
8.
Pourajam S, Kalantari E, Talebzadeh H, Mellali H, Sami R, Soltaninejad F, et al.
Front Cell Infect Microbiol
. 2022 Mar;
12:784130.
PMID: 35281440
Data on the prevalence of bacterial co-infections and secondary infection among adults with COVID-19 admitted to the intensive care unit (ICU) are rare. We aimed to determine the frequency of...
9.
Karimifar M, Pourajam S, Tahmasebi A, Mottaghi P
J Res Med Sci
. 2013 Aug;
18(3):234-8.
PMID: 23930122
Background: To determine the prevalence of cryoglobulins in Iranian patients with systemic lupus erythematosus (SLE) and evaluate the correlation of cryoglobulins with disease activity in these patients. Materials And Methods:...